APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rheumatic Disorders Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rheumatic Disorders Treatment Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchRheumatic Disorders Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheumatic Disorders Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Rheumatic Disorders Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheumatic Disorders Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheumatic Disorders Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Rheumatic Disorders Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rheumatic Disorders Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rheumatic Disorders Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rheumatic Disorders Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rheumatic Disorders Treatment include Stelara, Simponi, Rituxan, Remicade, Prolia, Orencia, Humira, Forteo and Enbrel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rheumatic Disorders Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rheumatic Disorders Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rheumatic Disorders Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rheumatic Disorders Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rheumatic Disorders Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rheumatic Disorders Treatment Market by Company

Stelara

Simponi

Rituxan

Remicade

Prolia

Orencia

Humira

Forteo

Enbrel

Cosentyx

Benlysta

Actemra

Rheumatic Disorders Treatment Segment by Type

Against Cell Surface Antigens

Acts on TNF-α

Acts on Interleukins and Interleukin Receptors

Act on Protein Kinase

Acts on Hormones and Hormone Receptors

Rheumatic Disorders Treatment Segment by Application

Hospital

Pharmacy

Other

Rheumatic Disorders Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheumatic Disorders Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheumatic Disorders Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheumatic Disorders Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rheumatic Disorders Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rheumatic Disorders Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Against Cell Surface Antigens Table 2. Major Company of Acts on TNF-α Table 3. Major Company of Acts on Interleukins and Interleukin Receptors Table 4. Major Company of Act on Protein Kinase Table 5. Major Company of Acts on Hormones and Hormone Receptors Table 6. Global Rheumatic Disorders Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 8. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Type (2021-2026) Table 9. Global Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 10. Global Rheumatic Disorders Treatment Sales Market Share in Value by Type (2021-2026) Table 11. Global Rheumatic Disorders Treatment Price by Type (2021-2026) & (US$/unit) Table 12. Global Rheumatic Disorders Treatment Sales by Type (2027-2032) & (k units) Table 13. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Type (2027-2032) Table 14. Global Rheumatic Disorders Treatment Sales by Type (2027-2032) & (US$ Million) Table 15. Global Rheumatic Disorders Treatment Sales Market Share in Value by Type (2027-2032) Table 16. Global Rheumatic Disorders Treatment Price by Type (2027-2032) & (US$/unit) Table 17. North America Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 18. North America Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 20. Europe Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 24. Latin America Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Rheumatic Disorders Treatment Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Rheumatic Disorders Treatment Sales by Type (2021-2026) & (US$ Million) Table 27. Rheumatic Disorders Treatment Industry Trends Table 28. Rheumatic Disorders Treatment Industry Drivers Table 29. Rheumatic Disorders Treatment Industry Opportunities and Challenges Table 30. Rheumatic Disorders Treatment Industry Restraints Table 31. Global Rheumatic Disorders Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Rheumatic Disorders Treatment Revenue Market Share by Company (2021-2026) Table 33. Global Rheumatic Disorders Treatment Sales by Company (2021-2026) & (k units) Table 34. Global Rheumatic Disorders Treatment Sales Share by Company (2021-2026) Table 35. Global Rheumatic Disorders Treatment Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Rheumatic Disorders Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Rheumatic Disorders Treatment Major Company Production Sites and Headquarters Table 38. Global Rheumatic Disorders Treatment Company, Product Type & Application Table 39. Global Rheumatic Disorders Treatment Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Rheumatic Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Rheumatic Disorders Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Rheumatic Disorders Treatment Sales by Region (2021-2026) & (k units) Table 44. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Region (2021-2026) Table 45. Global Rheumatic Disorders Treatment Sales by Region (2021-2026) & (US$ Million) Table 46. Global Rheumatic Disorders Treatment Sales Market Share in Value by Region (2021-2026) Table 47. Global Rheumatic Disorders Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Rheumatic Disorders Treatment Sales by Region (2027-2032) & (k units) Table 49. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Region (2027-2032) Table 50. Global Rheumatic Disorders Treatment Sales by Region (2027-2032) & (US$ Million) Table 51. Global Rheumatic Disorders Treatment Sales Market Share in Value by Region (2027-2032) Table 52. Global Rheumatic Disorders Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Rheumatic Disorders Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 55. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Application (2021-2026) Table 56. Global Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 57. Global Rheumatic Disorders Treatment Sales Market Share in Value by Application (2021-2026) Table 58. Global Rheumatic Disorders Treatment Price by Application (2021-2026) & (US$/unit) Table 59. Global Rheumatic Disorders Treatment Sales by Application (2027-2032) & (k units) Table 60. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Application (2027-2032) Table 61. Global Rheumatic Disorders Treatment Sales by Application (2027-2032) & (US$ Million) Table 62. Global Rheumatic Disorders Treatment Sales Market Share in Value by Application (2027-2032) Table 63. Global Rheumatic Disorders Treatment Price by Application (2027-2032) & (US$/unit) Table 64. North America Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 65. North America Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 67. Europe Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 71. Latin America Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Rheumatic Disorders Treatment Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Rheumatic Disorders Treatment Sales by Application (2021-2026) & (US$ Million) Table 74. Stelara Company Information Table 75. Stelara Business Overview Table 76. Stelara Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Stelara Rheumatic Disorders Treatment Product Portfolio Table 78. Stelara Recent Development Table 79. Simponi Company Information Table 80. Simponi Business Overview Table 81. Simponi Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Simponi Rheumatic Disorders Treatment Product Portfolio Table 83. Simponi Recent Development Table 84. Rituxan Company Information Table 85. Rituxan Business Overview Table 86. Rituxan Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Rituxan Rheumatic Disorders Treatment Product Portfolio Table 88. Rituxan Recent Development Table 89. Remicade Company Information Table 90. Remicade Business Overview Table 91. Remicade Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Remicade Rheumatic Disorders Treatment Product Portfolio Table 93. Remicade Recent Development Table 94. Prolia Company Information Table 95. Prolia Business Overview Table 96. Prolia Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Prolia Rheumatic Disorders Treatment Product Portfolio Table 98. Prolia Recent Development Table 99. Orencia Company Information Table 100. Orencia Business Overview Table 101. Orencia Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Orencia Rheumatic Disorders Treatment Product Portfolio Table 103. Orencia Recent Development Table 104. Humira Company Information Table 105. Humira Business Overview Table 106. Humira Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Humira Rheumatic Disorders Treatment Product Portfolio Table 108. Humira Recent Development Table 109. Forteo Company Information Table 110. Forteo Business Overview Table 111. Forteo Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Forteo Rheumatic Disorders Treatment Product Portfolio Table 113. Forteo Recent Development Table 114. Enbrel Company Information Table 115. Enbrel Business Overview Table 116. Enbrel Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Enbrel Rheumatic Disorders Treatment Product Portfolio Table 118. Enbrel Recent Development Table 119. Cosentyx Company Information Table 120. Cosentyx Business Overview Table 121. Cosentyx Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Cosentyx Rheumatic Disorders Treatment Product Portfolio Table 123. Cosentyx Recent Development Table 124. Benlysta Company Information Table 125. Benlysta Business Overview Table 126. Benlysta Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Benlysta Rheumatic Disorders Treatment Product Portfolio Table 128. Benlysta Recent Development Table 129. Actemra Company Information Table 130. Actemra Business Overview Table 131. Actemra Rheumatic Disorders Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Actemra Rheumatic Disorders Treatment Product Portfolio Table 133. Actemra Recent Development Table 134. North America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. North America Rheumatic Disorders Treatment Sales by Country (2021-2026) & (k units) Table 136. North America Rheumatic Disorders Treatment Sales Market Share by Country (2021-2026) Table 137. North America Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032) & (k units) Table 138. North America Rheumatic Disorders Treatment Sales Market Share Forecast by Country (2027-2032) Table 139. North America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Rheumatic Disorders Treatment Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Rheumatic Disorders Treatment Market Share by Country (2021-2026) Table 142. North America Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Rheumatic Disorders Treatment Market Share Forecast by Country (2027-2032) Table 144. Europe Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Europe Rheumatic Disorders Treatment Sales by Country (2021-2026) & (k units) Table 146. Europe Rheumatic Disorders Treatment Sales Market Share by Country (2021-2026) Table 147. Europe Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032) & (k units) Table 148. Europe Rheumatic Disorders Treatment Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Rheumatic Disorders Treatment Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Rheumatic Disorders Treatment Market Share by Country (2021-2026) Table 152. Europe Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Rheumatic Disorders Treatment Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Rheumatic Disorders Treatment Sales by Country (2021-2026) & (k units) Table 156. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032) & (k units) Table 158. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Rheumatic Disorders Treatment Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Rheumatic Disorders Treatment Market Share by Country (2021-2026) Table 162. Asia-Pacific Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Rheumatic Disorders Treatment Market Share Forecast by Country (2027-2032) Table 164. Latin America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Latin America Rheumatic Disorders Treatment Sales by Country (2021-2026) & (k units) Table 166. Latin America Rheumatic Disorders Treatment Sales Market Share by Country (2021-2026) Table 167. Latin America Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032) & (k units) Table 168. Latin America Rheumatic Disorders Treatment Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Rheumatic Disorders Treatment Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Rheumatic Disorders Treatment Market Share by Country (2021-2026) Table 172. Latin America Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Rheumatic Disorders Treatment Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Rheumatic Disorders Treatment Sales by Country (2021-2026) & (k units) Table 176. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032) & (k units) Table 178. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Rheumatic Disorders Treatment Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Rheumatic Disorders Treatment Market Share by Country (2021-2026) Table 182. Middle East and Africa Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Rheumatic Disorders Treatment Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Rheumatic Disorders Treatment Distributors List Table 187. Rheumatic Disorders Treatment Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Rheumatic Disorders Treatment Image Figure 2. Global Rheumatic Disorders Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rheumatic Disorders Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Rheumatic Disorders Treatment Sales (2021-2032) & (k units) Figure 5. Against Cell Surface Antigens Image Figure 6. Global Against Cell Surface Antigens Sales YoY Growth (2021-2032) & (k units) Figure 7. Acts on TNF-α Image Figure 8. Global Acts on TNF-α Sales YoY Growth (2021-2032) & (k units) Figure 9. Acts on Interleukins and Interleukin Receptors Image Figure 10. Global Acts on Interleukins and Interleukin Receptors Sales YoY Growth (2021-2032) & (k units) Figure 11. Act on Protein Kinase Image Figure 12. Global Act on Protein Kinase Sales YoY Growth (2021-2032) & (k units) Figure 13. Acts on Hormones and Hormone Receptors Image Figure 14. Global Acts on Hormones and Hormone Receptors Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Rheumatic Disorders Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Rheumatic Disorders Treatment Market Share by Type 2025 VS 2032 Figure 17. North America Rheumatic Disorders Treatment Sales Market Share in Volume by Type in 2025 Figure 18. North America Rheumatic Disorders Treatment Sales Market Share in Value by Type in 2025 Figure 19. Europe Rheumatic Disorders Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Europe Rheumatic Disorders Treatment Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share in Value by Type in 2025 Figure 23. Latin America Rheumatic Disorders Treatment Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Rheumatic Disorders Treatment Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Rheumatic Disorders Treatment Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Pharmacy Image Figure 32. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Rheumatic Disorders Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Rheumatic Disorders Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Rheumatic Disorders Treatment Sales Market Share in Volume by Application in 2025 Figure 38. North America Rheumatic Disorders Treatment Sales Market Share in Value by Application in 2025 Figure 39. Europe Rheumatic Disorders Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Europe Rheumatic Disorders Treatment Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Rheumatic Disorders Treatment Sales Market Share in Value by Application in 2025 Figure 43. Latin America Rheumatic Disorders Treatment Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Rheumatic Disorders Treatment Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Rheumatic Disorders Treatment Sales Market Share in Value by Application in 2025 Figure 47. North America Rheumatic Disorders Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Rheumatic Disorders Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Rheumatic Disorders Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Rheumatic Disorders Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Rheumatic Disorders Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Rheumatic Disorders Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Rheumatic Disorders Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Rheumatic Disorders Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Rheumatic Disorders Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Rheumatic Disorders Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Rheumatic Disorders Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Rheumatic Disorders Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Rheumatic Disorders Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Rheumatic Disorders Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Rheumatic Disorders Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Rheumatic Disorders Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Rheumatic Disorders Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Rheumatic Disorders Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Rheumatic Disorders Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Rheumatic Disorders Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Rheumatic Disorders Treatment Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Rheumatic Disorders Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Against Cell Surface Antigens
  • Acts on TNF-α
  • Acts on Interleukins and Interleukin Receptors
  • Act on Protein Kinase
  • Acts on Hormones and Hormone Receptors
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Stelara
  • Simponi
  • Rituxan
  • Remicade
  • Prolia
  • Orencia
  • Humira
  • Forteo
  • Enbrel
  • Cosentyx
  • Benlysta
  • Actemra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rheumatic Disorders Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rheumatic Disorders Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rheumatic Disorders Treatment Market by Type
  6. 1.3.1 Against Cell Surface Antigens
  7. 1.3.2 Acts on TNF-α
  8. 1.3.3 Acts on Interleukins and Interleukin Receptors
  9. 1.3.4 Act on Protein Kinase
  10. 1.3.5 Acts on Hormones and Hormone Receptors
  11. 1.4 Global Rheumatic Disorders Treatment Market Size by Type
  12. 1.4.1 Global Rheumatic Disorders Treatment Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Rheumatic Disorders Treatment Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Rheumatic Disorders Treatment Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Rheumatic Disorders Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Rheumatic Disorders Treatment Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Rheumatic Disorders Treatment Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Rheumatic Disorders Treatment Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Rheumatic Disorders Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rheumatic Disorders Treatment Industry Trends
  2. 2.2 Rheumatic Disorders Treatment Industry Drivers
  3. 2.3 Rheumatic Disorders Treatment Industry Opportunities and Challenges
  4. 2.4 Rheumatic Disorders Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rheumatic Disorders Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Rheumatic Disorders Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Rheumatic Disorders Treatment Price (2021-2026)
  4. 3.4 Global Rheumatic Disorders Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rheumatic Disorders Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Rheumatic Disorders Treatment Company, Product Type & Application
  7. 3.7 Global Rheumatic Disorders Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rheumatic Disorders Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rheumatic Disorders Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rheumatic Disorders Treatment Tier 1, Tier 2, and Tier 3
4 Rheumatic Disorders Treatment Regional Status and Outlook
  1. 4.1 Global Rheumatic Disorders Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rheumatic Disorders Treatment Historic Market Size by Region
  3. 4.2.1 Global Rheumatic Disorders Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rheumatic Disorders Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rheumatic Disorders Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rheumatic Disorders Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Rheumatic Disorders Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rheumatic Disorders Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rheumatic Disorders Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rheumatic Disorders Treatment by Application
  1. 5.1 Rheumatic Disorders Treatment Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Rheumatic Disorders Treatment Market Size by Application
  6. 5.2.1 Global Rheumatic Disorders Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rheumatic Disorders Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rheumatic Disorders Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rheumatic Disorders Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rheumatic Disorders Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rheumatic Disorders Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rheumatic Disorders Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rheumatic Disorders Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Stelara
  2. 6.1.1 Stelara Company Information
  3. 6.1.2 Stelara Business Overview
  4. 6.1.3 Stelara Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Stelara Rheumatic Disorders Treatment Product Portfolio
  6. 6.1.5 Stelara Recent Developments
  7. 6.2 Simponi
  8. 6.2.1 Simponi Company Information
  9. 6.2.2 Simponi Business Overview
  10. 6.2.3 Simponi Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Simponi Rheumatic Disorders Treatment Product Portfolio
  12. 6.2.5 Simponi Recent Developments
  13. 6.3 Rituxan
  14. 6.3.1 Rituxan Company Information
  15. 6.3.2 Rituxan Business Overview
  16. 6.3.3 Rituxan Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Rituxan Rheumatic Disorders Treatment Product Portfolio
  18. 6.3.5 Rituxan Recent Developments
  19. 6.4 Remicade
  20. 6.4.1 Remicade Company Information
  21. 6.4.2 Remicade Business Overview
  22. 6.4.3 Remicade Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Remicade Rheumatic Disorders Treatment Product Portfolio
  24. 6.4.5 Remicade Recent Developments
  25. 6.5 Prolia
  26. 6.5.1 Prolia Company Information
  27. 6.5.2 Prolia Business Overview
  28. 6.5.3 Prolia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Prolia Rheumatic Disorders Treatment Product Portfolio
  30. 6.5.5 Prolia Recent Developments
  31. 6.6 Orencia
  32. 6.6.1 Orencia Company Information
  33. 6.6.2 Orencia Business Overview
  34. 6.6.3 Orencia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Orencia Rheumatic Disorders Treatment Product Portfolio
  36. 6.6.5 Orencia Recent Developments
  37. 6.7 Humira
  38. 6.7.1 Humira Company Information
  39. 6.7.2 Humira Business Overview
  40. 6.7.3 Humira Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Humira Rheumatic Disorders Treatment Product Portfolio
  42. 6.7.5 Humira Recent Developments
  43. 6.8 Forteo
  44. 6.8.1 Forteo Company Information
  45. 6.8.2 Forteo Business Overview
  46. 6.8.3 Forteo Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Forteo Rheumatic Disorders Treatment Product Portfolio
  48. 6.8.5 Forteo Recent Developments
  49. 6.9 Enbrel
  50. 6.9.1 Enbrel Company Information
  51. 6.9.2 Enbrel Business Overview
  52. 6.9.3 Enbrel Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Enbrel Rheumatic Disorders Treatment Product Portfolio
  54. 6.9.5 Enbrel Recent Developments
  55. 6.10 Cosentyx
  56. 6.10.1 Cosentyx Company Information
  57. 6.10.2 Cosentyx Business Overview
  58. 6.10.3 Cosentyx Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cosentyx Rheumatic Disorders Treatment Product Portfolio
  60. 6.10.5 Cosentyx Recent Developments
  61. 6.11 Benlysta
  62. 6.11.1 Benlysta Company Information
  63. 6.11.2 Benlysta Business Overview
  64. 6.11.3 Benlysta Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Benlysta Rheumatic Disorders Treatment Product Portfolio
  66. 6.11.5 Benlysta Recent Developments
  67. 6.12 Actemra
  68. 6.12.1 Actemra Company Information
  69. 6.12.2 Actemra Business Overview
  70. 6.12.3 Actemra Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Actemra Rheumatic Disorders Treatment Product Portfolio
  72. 6.12.5 Actemra Recent Developments
7 North America by Country
  1. 7.1 North America Rheumatic Disorders Treatment Sales by Country
  2. 7.1.1 North America Rheumatic Disorders Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rheumatic Disorders Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rheumatic Disorders Treatment Market Size by Country
  6. 7.2.1 North America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rheumatic Disorders Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rheumatic Disorders Treatment Sales by Country
  2. 8.1.1 Europe Rheumatic Disorders Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rheumatic Disorders Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rheumatic Disorders Treatment Market Size by Country
  6. 8.2.1 Europe Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rheumatic Disorders Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rheumatic Disorders Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Rheumatic Disorders Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rheumatic Disorders Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rheumatic Disorders Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rheumatic Disorders Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rheumatic Disorders Treatment Sales by Country
  2. 10.1.1 South America Rheumatic Disorders Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rheumatic Disorders Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rheumatic Disorders Treatment Market Size by Country
  6. 10.2.1 South America Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rheumatic Disorders Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rheumatic Disorders Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Rheumatic Disorders Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rheumatic Disorders Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rheumatic Disorders Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rheumatic Disorders Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Rheumatic Disorders Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rheumatic Disorders Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rheumatic Disorders Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rheumatic Disorders Treatment Value Chain Analysis
  2. 12.1.1 Rheumatic Disorders Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rheumatic Disorders Treatment Production Mode & Process
  7. 12.2 Rheumatic Disorders Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rheumatic Disorders Treatment Distributors
  10. 12.2.3 Rheumatic Disorders Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst